GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pro-Dex Inc (NAS:PDEX) » Definitions » Beneish M-Score
中文

Pro-Dex (Pro-Dex) Beneish M-Score : -2.54 (As of Apr. 25, 2024)


View and export this data going back to 1986. Start your Free Trial

What is Pro-Dex Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.54 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Pro-Dex's Beneish M-Score or its related term are showing as below:

PDEX' s Beneish M-Score Range Over the Past 10 Years
Min: -3.52   Med: -1.99   Max: -0.42
Current: -2.54

During the past 13 years, the highest Beneish M-Score of Pro-Dex was -0.42. The lowest was -3.52. And the median was -1.99.


Pro-Dex Beneish M-Score Historical Data

The historical data trend for Pro-Dex's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pro-Dex Beneish M-Score Chart

Pro-Dex Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.91 -2.00 -1.12 -1.40 -2.65

Pro-Dex Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.57 -1.80 -2.65 -1.96 -2.54

Competitive Comparison of Pro-Dex's Beneish M-Score

For the Medical Instruments & Supplies subindustry, Pro-Dex's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pro-Dex's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pro-Dex's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Pro-Dex's Beneish M-Score falls into.



Pro-Dex Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Pro-Dex for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9904+0.528 * 0.9503+0.404 * 0.5695+0.892 * 1.0903+0.115 * 0.7118
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8346+4.679 * 0.000778-0.327 * 0.7861
=-2.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $13.17 Mil.
Revenue was 12.588 + 11.938 + 10.639 + 13.079 = $48.24 Mil.
Gross Profit was 2.802 + 3.658 + 3.359 + 3.811 = $13.63 Mil.
Total Current Assets was $36.60 Mil.
Total Assets was $51.43 Mil.
Property, Plant and Equipment(Net PPE) was $13.21 Mil.
Depreciation, Depletion and Amortization(DDA) was $1.04 Mil.
Selling, General, & Admin. Expense(SGA) was $4.34 Mil.
Total Current Liabilities was $9.99 Mil.
Long-Term Debt & Capital Lease Obligation was $9.64 Mil.
Net Income was 0.5 + -0.615 + 3.806 + 1.313 = $5.00 Mil.
Non Operating Income was -0.04 + -2.553 + 3.667 + -0.177 = $0.90 Mil.
Cash Flow from Operations was 0.71 + 0.392 + 0.627 + 2.338 = $4.07 Mil.
Total Receivables was $12.20 Mil.
Revenue was 11.282 + 11.087 + 12.615 + 9.265 = $44.25 Mil.
Gross Profit was 2.623 + 2.956 + 3.443 + 2.858 = $11.88 Mil.
Total Current Assets was $31.39 Mil.
Total Assets was $47.58 Mil.
Property, Plant and Equipment(Net PPE) was $13.56 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.74 Mil.
Selling, General, & Admin. Expense(SGA) was $4.77 Mil.
Total Current Liabilities was $11.67 Mil.
Long-Term Debt & Capital Lease Obligation was $11.44 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(13.169 / 48.244) / (12.195 / 44.249)
=0.272967 / 0.275599
=0.9904

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(11.88 / 44.249) / (13.63 / 48.244)
=0.268481 / 0.282522
=0.9503

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (36.6 + 13.208) / 51.427) / (1 - (31.387 + 13.562) / 47.579)
=0.031482 / 0.055276
=0.5695

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=48.244 / 44.249
=1.0903

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.744 / (0.744 + 13.562)) / (1.041 / (1.041 + 13.208))
=0.052006 / 0.073058
=0.7118

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(4.344 / 48.244) / (4.774 / 44.249)
=0.090042 / 0.107889
=0.8346

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((9.643 + 9.99) / 51.427) / ((11.44 + 11.665) / 47.579)
=0.381764 / 0.485613
=0.7861

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(5.004 - 0.897 - 4.067) / 51.427
=0.000778

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Pro-Dex has a M-score of -2.54 suggests that the company is unlikely to be a manipulator.


Pro-Dex Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Pro-Dex's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Pro-Dex (Pro-Dex) Business Description

Traded in Other Exchanges
Address
2361 McGaw Avenue, Irvine, CA, USA, 92614
Pro-Dex Inc is engaged in designing, developing, and manufacturing powered rotary drive surgical and dental instruments used primarily in the orthopedic, spine, maxocranial facial and dental markets. The company also designs and manufactures multi-axis motion control systems used in factory automation and scientific research markets. In addition, the company provides engineering consulting and placement services, as well as quality and regulatory consulting services. Most of the company's revenue is derived from designing, developing, and manufacturing surgical devices for the medical device and dental industries.
Executives
Angelita Rebamontan Domingo director 1431 MADISON ST., TUSTIN CA 92782
Van Kirk Richard Lee Jr director, officer: Chief Executive Officer 34 DEER CREEK, IRVINE CA 92604
Philp Katrina Marie Kramer director 5501 NANTUCKET PL, MINNETONKA MN 55345
Farrell William James Iii director 20200 COTTAGEWOOD RD, DEEPHAVEN MN 55331
Peter O. Haeg 10 percent owner 12701 WHITEWATER DR, SUITE 190, MINNETONKA MN 55343
Alisha Charlton officer: Chief Financial Officer 25541 COMMERCENTRE DRIVE, LAKE FOREST CA 92630
Nicholas John Swenson 10 percent owner 5000 WEST 36TH STREET, SUITE 130, MINNEAPOLIS MN 55416
Raymond E Cabillot director 3033 EXCELSIOR BLVD., STE 560, MINNEAPOLIS MN 55416
David Hovda director
Farnam Street Partners Lp /mn 10 percent owner 3033 EXCELSIOR BOULEVARD, MINNEAPOLIS, MINNEAPOLIS MN 55416
Ao Partners I, Lp 10 percent owner 5000 WEST 36TH STREET, SUITE 130, MINNEAPOLIS MN 55416
David Holder director 1052 CHARWOOD LANE, SANTA ANA CA 92705
William L Healey director 101 BULLITT LANE, STE 450, LOUISVILLE KY 40222
Michael J Berthelot director P O BOX 7277, RANCHO SANTA FE CA 92067
George J Isaac director 36 WHISPER DRIVE, WORCESTER MA 01609